Demonstrating Feasibility of an Opportunistic Sampling Approach for Pharmacokinetic Studies of β‐Lactam Antibiotics in Critically Ill Children-Reference-Cited by-同舟云学术

Demonstrating Feasibility of an Opportunistic Sampling Approach for Pharmacokinetic Studies of β‐Lactam Antibiotics in Critically Ill Children

Published:2020-10-27 Issue:4 Volume:61 Page:565-573
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Tang Girdwood Sonya C.¹²³^ORCID,Tang Peter H.³⁴,Murphy Mark E.²⁵,Chamberlain Andrea R.⁶,Benken Laura A.⁷,Jones Rhonda L.⁷,Stoneman Erin M.⁷,Kaplan Jennifer M.³⁷,Vinks Alexander A.²³

Affiliation:

1. Division of Hospital Medicine, Department of Pediatrics Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

2. Division of Clinical Pharmacology, Department of Pediatrics Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

3. Department of Pediatrics University of Cincinnati College of Medicine Cincinnati Ohio USA

4. Division of Pathology, Department of Pediatrics Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

5. Division of Infectious Diseases, Department of Pediatrics Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

6. Department of Pharmacy Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

7. Division of Critical Care Medicine, Department of Pediatrics Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

Funder

National Center for Advancing Translational Sciences

Cincinnati Children's Hospital Medical Center

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1773

Reference27 articles.

1. Application of Antibiotic Pharmacodynamics and Dosing Principles in Patients With Sepsis

2. Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization

3. Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review

4. Defining the impact of severity of illness on time above the MIC threshold for cefepime in Gram‐negative bacteraemia: a 'Goldilocks' window;Miglis C;Int J Antimicrob Agents,2017

5. Innovative clinical trial design for pediatric therapeutics

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of pharmacokinetic target attainment and hematological toxicity of linezolid in pediatric patients;European Journal of Clinical Pharmacology;2024-08-25

2. Pharmacokinetic Factors Associated With Early Meropenem Target Attainment in Pediatric Severe Sepsis;Pediatric Critical Care Medicine;2024-08-20

3. Acute kidney injury is associated with abnormal cefepime exposure among critically ill children and young adults;Pediatric Nephrology;2024-08-16

4. Identifying optimal dosing strategies for meropenem in the paediatric intensive care unit through modelling and simulation;Journal of Antimicrobial Chemotherapy;2024-08-02

5. Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring;Antibiotics;2024-07-20